Saniona progresses its Kv7 epilepsy program into Lead
PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it has progressed its promising Kv7...
Source: globenewswire.com
Stay updated with breaking news from Lead Optimization Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it has progressed its promising Kv7...
PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it has progressed its promising Kv7 epilepsy program into the Lead Optimization